ArticleClinical journal of gastroenterology2026
Anti-TNF-refractory inflammatory bowel disease associated with a novel XIAP frameshift variant successfully treated with ustekinumab.
Natsuki Ito et al.PubMed ↗Publisher ↗
No numbers read from the abstract.